(+)-Vorozole

VOROZOLE is a small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Rivizor, Vorozolum, 6-((4-chlorophenyl)-(1H-1, 2 and 4-triazol-1-yl)methyl)-1-methyl-1H-benzotriazole. Its PubChem CID is 6918191.

CAS No 129731-10-8
Molecular Formula C16H13ClN6
Molecular Weight 324.77 g/mol
Synonyms 6-[(S)-(4-chlorophenyl)-(1,2,4-triazol-1-yl)methyl]-1-methylbenzotriazole

Frequently Asked Questions